The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

N.D. Selezneva

Mental Health Research Center

S.I. Gavrilova

Mental Health Research Centre

Cerebrolysin Treatment Reduces the Risk of Mild Cognitive Decline to Dementia in 1st-Degree Relatives of Alzheimer’s Patients: A Prospective Comparative Study

Authors:

N.D. Selezneva, S.I. Gavrilova

More about the authors

Views: 845

Downloaded: 20


To cite this article:

Selezneva ND, Gavrilova SI. Cerebrolysin Treatment Reduces the Risk of Mild Cognitive Decline to Dementia in 1st-Degree Relatives of Alzheimer’s Patients: A Prospective Comparative Study. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(8):90‑97. (In Russ.)
https://doi.org/10.17116/jnevro202312308190

Recommended articles:
Cere­brolysin in the treatment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3):20-25
Obstructive sleep apnea — unde­restimated cognitive impairments risk factor. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(8):36-41
Augmentation therapy of resi­stant schi­zophrenia with rhythmic transcranial magnetic stimulation. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(8):107-114
Modern achievements in the diagnosis and treatment of glaucoma. Russian Annals of Ophthalmology. 2023;(3):96-106

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.